tm logo
EXOKERYX
Live/Pending
RESPONSE AFTER NON-FINAL ACTION - ENTERED

final action

on 13 Mar 2024

Last Applicant/ Owned by

3030 Bunker Hill St. Suite 117D

San Diego

CA

92109

Serial Number

97680953 filed on 16th Nov 2022

Registration Number

N/A

Correspondent Address

John W. Olivo, Jr.

OLIVO IP LAW GROUP, P.C.

9440 SANTA MONICA BLVD., STE 301

C/O OLIVO IP GROUP, INC.

BEVERLY HILLS,CA 90210

Filing Basis

1. filed as use application

2. use application currently

Disclaimer

NO DATA

EXOKERYX

DNA, RNA, protein, lipid, metabolite, biomarker analysis services in the fields of nucleic acid sequencing, proteomics, methylomics, metabolomics, diagnostics, diagnostic research, clinical research, drug development, pharmaceutical research, life sciences, exosomics, lipidomics, genetics, genomics, biotechnology, forensics, food safety, agriculture, laboratory research, scientific research, medicRead More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


DNA, RNA, protein, lipid, metabolite, biomarker analysis services in the fields of nucleic acid sequencing, proteomics, methylomics, metabolomics, diagnostics, diagnostic research, clinical research, drug development, pharmaceutical research, life sciences, exosomics, lipidomics, genetics, genomics, biotechnology, forensics, food safety, agriculture, laboratory research, scientific research, medical research, oncology, neurodegeneration, infectious disease. Providing on-line non-downloadable computer search engine software for use in the fields of nucleic acid sequencing, proteomics, methylomics, metabolomics, diagnostics, diagnostic research, clinical research, drug development, pharmaceutical research, life sciences, exosomics, lipidomics, genetics, genomics, biotechnology, forensics, food safety, agriculture, laboratory research, scientific research, medical research, oncology, neurodegeneration, infectious disease; providing online non-downloadable computer software for the custom design and ordering of assays and reagents in the fields of nucleic acid sequencing, proteomics, methylomics, metabolomics, diagnostics, diagnostic research, clinical research, drug development, pharmaceutical research, life sciences, exosomics, lipidomics, genetics, genomics, biotechnology, forensics, food safety, agriculture, laboratory research, scientific research, medical research, oncology, neurodegeneration, infectious disease. Scientific laboratory services; Medical laboratory services; Computer services, namely, cloud hosting provider services and onsite provider services in the nature of onsite management of information technology (IT) systems of others that allows users to store, analyze and share information over a global computer network in the fields of nucleic acid sequencing, proteomics, methylomics, metabolomics, diagnostics, diagnostic research, clinical research, drug development, pharmaceutical research, life sciences, exosomics, lipidomics, genetics, genomics, biotechnology, forensics, food safety, agriculture, laboratory research, scientific research, medical research, oncology, neurodegeneration, infectious disease


First Use Date in General

13th Oct 2021

First Use Date in Commerce

15th Nov 2021

Class [005]
Pharmaceutical Products


Kits, reagents, enzymes, enzyme substrates, antibodies, buffers, nucleic acids, biological agents, assays, conjugation chemistries, and chemical groups for in vitro diagnostic use; kits, reagents, enzymes, enzyme substrates, antibodies, buffers, nucleic acids, biological agents, assays, conjugation chemistries, and chemical groups for veterenary use; kits, reagents, enzymes, enzyme substrates, antibodies, buffers, nucleic acids, biological agents, assays, conjugation chemistries, and chemical groups for clinical use; kits, comprising reagents, enzymes, enzyme substrates, monoclonal antibodies, buffers, nucleic acids, biological agents, and assays, for use in the fields of nucleic acid sequencing, proteomics, methylomics, metabolomics, diagnostics, diagnostic research, clinical research, drug development, pharmaceutical research, life sciences, exosomics, lipidomics, genetics, genomics, biotechnology, forensics, laboratory research, scientific research, medical research, oncology, neurodegeneration, infectious disease for medical purposes


First Use Date in General

13th Oct 2021

First Use Date in Commerce

15th Nov 2021

Class [001]
Chemical Products


Kits comprising reagents, enzymes, enzyme substrates, antibodies, buffers, nucleic acids, biological agents, assays, for scientific, non-medical, or medical research use; Kits comprising reagents, enzymes, enzyme substrates, antibodies, buffers, nucleic acids, biological agents, and assays, conjugation chemistries, and chemical groups for scientific or medical research use; kits, reagents, enzymes, enzyme substrates, antibodies, buffers, nucleic acids, biological agents, assays, conjugation chemistries, and chemical groups for veterenary use; kits, comprising reagents, enzymes, enzyme substrates, monoclonal antibodies, buffers, nucleic acids, biological agents, and assays, for use in the fields of nucleic acid sequencing, proteomics, methylomics, metabolomics, diagnostics, diagnostic research, clinical research, drug development, pharmaceutical research, life sciences, exosomics, lipidomics, genetics, genomics, biotechnology, forensics, laboratory research, scientific research, medical research, oncology, neurodegeneration, infectious disease for scientific research


First Use Date in General

13th Oct 2021

First Use Date in Commerce

15th Nov 2021

Mark Details


Serial Number

No 97680953

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
13th Mar 2024TEAS/EMAIL CORRESPONDENCE ENTERED
12th Mar 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
12th Mar 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
12th Dec 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
12th Dec 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
12th Sep 2023NON-FINAL ACTION WRITTEN
12th Sep 2023NON-FINAL ACTION E-MAILED
12th Sep 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
29th Aug 2023ASSIGNED TO EXAMINER
07th Dec 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED